Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Providencia spp. as emerging clinical pathogens in the era of antimicrobial resistance: From opportunism to global threat: A review.

Created on 19 Nov 2026

Authors

Turki Asiri

Published in

Acta microbiologica et immunologica Hungarica. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Providencia species are increasingly recognized as clinically important opportunistic pathogens, particularly in healthcare settings where the presence of vulnerable patients, prolonged hospital stays, invasive devices, and exposure to antibiotics contribute to their persistence and spread. Although Providencia spp. are historically viewed as relatively rare causes of human infection, some species such as Providencia stuartii and Providencia rettgeri have emerged as significant pathogens of urinary tract, bloodstream, respiratory, and other healthcare-associated infections. Recent studies have greatly expanded our understanding of this genus, revealing previously unknown species diversity, improved taxonomy, and identified the emergence of internationally disseminated high-risk lineages. Of particular concern is the growing burden of antimicrobial resistance. Providencia combines an intrinsically limited susceptibility profile with an increasing ability to acquire extended-spectrum β-lactamases, carbapenemases, aminoglycoside resistance determinants, quinolone resistance mechanisms, and other resistance genes. Carbapenem resistance, particularly that mediated by NDM-type metallo-β-lactamases (MBLs), has become a major clinical threat. Of great concern, the emergence of multidrug-resistant and extensively drug-resistant strains was reported in Providencia and it is increasingly limiting treatment options. This review summarizes the latest developments in taxonomy, epidemiology, healthcare-associated transmission, mobile genetic elements, antimicrobial resistance, and therapeutic challenges for Providencia species, with emphasis on necessity of future research to strengthen genomic surveillance and antimicrobial resistance monitoring, promote the prudent use of antimicrobials, implement infection prevention measures, and conduct future therapeutic studies to limit further spread and improve the management of these emerging pathogens.

PMID:
43049807
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement